×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| INDOCO REMEDIES LTD. | 3981.1 | -280.6 | 3925.3 | -3.04 | 2,589 | |
| Shalby Limited | 2421.77 | 256.95 | 2366.54 | 2.39 | 2531 | 32.1 |
| NOVARTIS INDIA LTD. | NA | NA | NA | NA | 2291 | 22.3 |
Indoco Remedies Ltd., with Security Code 532612, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 427.5 | 422.9 | 473.4 | 449.1 | 445.5 | 401.4 | 396.5 | 373.0 | 347.3 | 392.5 |
| Expenses | 363.3 | 360.0 | 401.0 | 383.8 | 388.1 | 349.9 | 343.7 | 352.8 | 343.7 | 377.7 |
| Operating Profit | 64.2 | 62.9 | 72.4 | 65.3 | 57.4 | 51.6 | 52.9 | 20.1 | 3.5 | 14.8 |
| OPM % | 15.01% | 14.88% | 15.3% | 14.54% | 12.88% | 12.85% | 13.33% | 5.4% | 1.01% | 3.78% |
| Other Income | 0.5 | 0.4 | 1.1 | -5.3 | 23.8 | 3.5 | 4.2 | 5.3 | 6.5 | 5.6 |
| Interest | 8.6 | 7.8 | 8.1 | 10.0 | 10.9 | 11.9 | 14.8 | 14.0 | 16.0 | 23.6 |
| Depreciation | 17.7 | 19.9 | 21.4 | 23.0 | 23.7 | 23.7 | 24.9 | 24.8 | 24.9 | 25.2 |
| Profit before tax | 38.3 | 35.7 | 44.0 | 35.2 | 26.8 | 19.5 | 17.4 | -14.4 | -30.9 | -28.4 |
| Tax % | -33.8% | -27.3% | -24.7% | -25.9% | -19.2% | -23.4% | -26.4% | -23.4% | 0% | 1.2% |
| Net Profit | 25.4 | 25.9 | 33.1 | 20.0 | 37.6 | 15.0 | 12.8 | -10.2 | -26.2 | -28.1 |
| EPS in Rs | 2.75 | 2.81 | 3.59 | 2.17 | 4.07 | 1.62 | 1.39 | -1.11 | 0 | -3.04 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 399.2 | 428.2 | 426.5 | 481.7 | 459.4 | 449.6 | 431.5 | 432.7 | 410.6 | 390.2 |
| Expenses | 337.2 | 363.4 | 365.3 | 410.4 | 396.5 | 400.8 | 383.7 | 392.4 | 398.5 | 390.9 |
| Operating Profit | 62.0 | 64.8 | 61.2 | 71.4 | 62.9 | 48.9 | 47.8 | 40.3 | 12.0 | -0.7 |
| OPM % | 15.54% | 15.13% | 14.34% | 14.82% | 13.69% | 10.87% | 11.07% | 9.3% | 2.93% | -0.19% |
| Other Income | 0.4 | 0.5 | 0.4 | 4.4 | -5.9 | 22.4 | 1.0 | 1.6 | 1.8 | 2.0 |
| Interest | 7.0 | 8.6 | 7.8 | 8.1 | 10.1 | 12.1 | 14.3 | 17.8 | 16.1 | 18.0 |
| Depreciation | 17.2 | 17.7 | 19.9 | 21.4 | 24.4 | 26.2 | 27.5 | 28.8 | 28.7 | 28.8 |
| Profit before tax | 38.2 | 38.9 | 33.9 | 46.3 | 30.8 | 13.3 | 7.0 | -4.8 | -32.0 | -45.5 |
| Tax % | -26.3% | -33.7% | -28.7% | -23.9% | -31.2% | -33.2% | -73.9% | 106.8% | -8.3% | 0% |
| Net Profit | 28.1 | 25.8 | 24.2 | 35.2 | 15.6 | 22.0 | 1.8 | -10.0 | -28.4 | -41.3 |
| EPS in Rs | 3.05 | 2.8 | 2.62 | 3.82 | 1.69 | 2.39 | 0.2 | -1.08 | -3.08 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | 0% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -109% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | 3% |
| 3 Years: | -12% |
| 1 Year: | -22% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 3% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -184% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | 3% |
| 3 Years: | -12% |
| 1 Year: | -22% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|